Comprehensive Guide to tert-butyl (2R)-2-methyl-4-oxopiperidine-1-carboxylate (CAS No. 790667-43-5): Properties, Applications, and Market Insights
tert-butyl (2R)-2-methyl-4-oxopiperidine-1-carboxylate (CAS No. 790667-43-5) is a specialized chiral compound widely used in pharmaceutical synthesis and organic chemistry research. This piperidine derivative features a tert-butyl carbamate protecting group and a ketone functionality at the 4-position, making it a versatile building block for drug discovery. The compound's (2R)-stereochemistry is particularly valuable for creating enantiomerically pure pharmaceuticals, addressing the growing demand for chiral drugs in modern medicine.
The molecular structure of tert-butyl (2R)-2-methyl-4-oxopiperidine-1-carboxylate combines several pharmacologically important features: a piperidine ring (common in CNS drugs), a protected amine (allowing selective deprotection), and a carbonyl group (enabling further derivatization). With a molecular weight of 213.27 g/mol and the formula C11H19NO3, this compound has become increasingly important in medicinal chemistry, particularly for developing neurological therapeutics and enzyme inhibitors.
Recent trends in pharmaceutical research have significantly increased interest in chiral building blocks like 790667-43-5. The global push for more effective and safer drugs has made enantiomerically pure intermediates crucial for drug development. This compound serves as a key intermediate in synthesizing various biologically active molecules, particularly those targeting G-protein coupled receptors (GPCRs) and neurotransmitter systems. Its stability under various conditions makes it particularly valuable for multi-step synthetic routes.
The synthetic applications of tert-butyl (2R)-2-methyl-4-oxopiperidine-1-carboxylate are extensive. Chemists frequently use it to construct complex heterocycles through reactions like reductive amination, nucleophilic addition to the carbonyl group, or ring-opening transformations. The tert-butyloxycarbonyl (Boc) protecting group can be selectively removed under acidic conditions, allowing for further functionalization of the nitrogen atom. This flexibility makes the compound valuable for creating diverse molecular architectures in drug discovery programs.
From a commercial perspective, CAS 790667-43-5 has seen growing demand in the pharmaceutical fine chemicals market. Suppliers typically offer this compound with high enantiomeric purity (>98% ee) to meet the stringent requirements of drug development. The current market trend shows increasing interest in custom synthesis of such chiral building blocks, with particular growth in contract research organizations serving the neurological drug development sector. Proper storage recommendations include keeping the compound in a cool, dry place under inert atmosphere to maintain its stability.
Quality control for tert-butyl (2R)-2-methyl-4-oxopiperidine-1-carboxylate typically involves HPLC analysis for purity assessment, chiral chromatography to confirm enantiomeric excess, and spectroscopic methods (NMR, IR, MS) for structural verification. The compound's characterization data, including specific rotation and spectral properties, are crucial for researchers to confirm identity and purity before use in sensitive synthetic applications. These quality parameters align with current Good Manufacturing Practice (GMP) standards for pharmaceutical intermediates.
Recent scientific literature highlights innovative applications of this chiral piperidine derivative in drug discovery. Several studies have utilized it as a starting material for protein kinase inhibitors and neuroprotective agents. The compound's rigid structure and defined stereochemistry make it particularly useful for creating conformationally constrained analogs of biologically active molecules. These applications align with current research priorities in precision medicine and targeted therapies.
Environmental and handling considerations for 790667-43-5 follow standard laboratory safety protocols. While not classified as hazardous, proper personal protective equipment (PPE) including gloves and safety glasses is recommended when handling. The compound should be used in well-ventilated areas, reflecting the pharmaceutical industry's increasing focus on green chemistry principles and sustainable synthesis practices.
The future outlook for tert-butyl (2R)-2-methyl-4-oxopiperidine-1-carboxylate appears promising, particularly with the growing emphasis on chiral drug development and central nervous system therapeutics. As pharmaceutical companies continue to invest in neurological disorder treatments and specialty medicines, demand for high-quality chiral intermediates like this compound is expected to rise. Ongoing research into its derivatives may uncover new therapeutic applications, further expanding its importance in medicinal chemistry.
For researchers considering CAS 790667-43-5 for their projects, several key factors should be evaluated: the required enantiomeric purity for the intended application, suitable protection-deprotection strategies in synthetic routes, and optimal storage conditions to maintain compound integrity. These considerations are particularly important in light of current trends toward quality by design (QbD) in pharmaceutical development and the increasing regulatory requirements for drug substance characterization.
